Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “neurofibromatosis1 (NF1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03826940
What this trial is testing

From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1

Who this might be right for
Autism Spectrum DisorderNeurofibromatosis 1
University of Coimbra 16
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+21 more
Masonic Cancer Center, University of Minnesota 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT03363217
What this trial is testing

Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.

Who this might be right for
Low-grade GliomaPlexiform NeurofibromaCentral Nervous System Glioma
St. Justine's Hospital 114
Not applicableStudy completedNCT01776125
What this trial is testing

Genetic Evaluation of NF1 and Scoliosis Patients

Who this might be right for
Neurofibromatosis 1Scoliosis
University of Minnesota 59
Early research (Phase 1)Study completedNCT04730583
What this trial is testing

Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

Who this might be right for
Cutaneous Neurofibroma
Massachusetts General Hospital 34
Testing effectiveness (Phase 2)Looking for participantsNCT06159166
What this trial is testing

Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).

Who this might be right for
NF1Cutaneous NeurofibromaMonotherapy
Johns Hopkins University 24
Testing effectiveness (Phase 2)Study completedNCT00634270
What this trial is testing

A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1
University of Alabama at Birmingham 58
Not applicableLooking for participantsNCT06222203
What this trial is testing

Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

Who this might be right for
Neurofibromatosis 1Nerve Sheath Neoplasms
National Cancer Institute (NCI) 225
Large-scale testing (Phase 3)Active Not RecruitingNCT05913037
What this trial is testing

FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Plexiform NeurofibromaNF1
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 167
Early research (Phase 1)Ended earlyNCT04800822
What this trial is testing

PF-07284892 in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Pfizer 53
Not applicableStudy completedNCT01595139
What this trial is testing

MicroRNAs in Patients With Neurofibromatosis Type 1

Who this might be right for
GliomaNeurofibromatosis Type 1
Ann & Robert H Lurie Children's Hospital of Chicago 9
Not applicableNot Yet RecruitingNCT07077408
What this trial is testing

ICanCope With NF: Innovating an Efficacious Digital Self-management and Transitional Care Program for Adolescents With Neurofibromatosis

Who this might be right for
Neurofibromatosis 1
The Hospital for Sick Children 60
Not applicableStudy completedNCT01058330
What this trial is testing

Effects of Physical Training on Bone and Muscle Quality, Muscle Strength, and Motor Coordination in Children With NF1

Who this might be right for
Neurofibromatosis Type 1
Shriners Hospitals for Children 36
Testing effectiveness (Phase 2)Looking for participantsNCT04750928
What this trial is testing

Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas

Who this might be right for
Neurofibromatosis 1
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Looking for participantsNCT05849662
What this trial is testing

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Who this might be right for
Leukemia, Juvenile MyelomonocyticJMMLJCML+2 more
Therapeutic Advances in Childhood Leukemia Consortium 58
Testing effectiveness (Phase 2)Study completedNCT02332902
What this trial is testing

Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T

Who this might be right for
Neurofibromatosis 1
The University of Texas Health Science Center, Houston 24
Testing effectiveness (Phase 2)Looking for participantsNCT06541847
What this trial is testing

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis Type 1
Healx Limited 25
Not applicableStudy completedNCT00026780
What this trial is testing

Eligibility Screening for a NCI Pediatric Oncology Branch Research Study

Who this might be right for
Ewing SarcomaOsteosarcomaNeuroblastoma+2 more
National Cancer Institute (NCI) 1,720
Testing effectiveness (Phase 2)Study completedNCT02839720
What this trial is testing

Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma

Who this might be right for
Cutaneous NeurofibromaNeurofibromatosis Type 1Optic Nerve Glioma
National Cancer Institute (NCI) 11
Not applicableActive Not RecruitingNCT00924196
What this trial is testing

Natural History Study of Patients With Neurofibromatosis Type I

Who this might be right for
Neurofibromatosis Type 1Malignant Peripheral Nerve Sheath TumorPlexiform Neurofibroma+2 more
National Cancer Institute (NCI) 259
Next Page